Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules

Drug major Glenmark Pharmaceuticals on Friday said it has received final nod from the health regulator for Fingolimod capsules.

Glenmark Pharma gets green signal for clinical trials of Favipiravir tablets on COVID-19 patients

Glenmark Pharmaceuticals on Thursday said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

Glenmark shares hit 52-week low on USFDA warning letter